The distributions of the three genotypes of VDR FokI SNPs were significantly different between progression group and control group, indicating that VDR FokI SNPs may be a risk factor for BPH progression and subject with heterozygote of “ff” is likely to develop BPH progression (Table 5: P = 0.009). The gene discussed is VDR; the disease is benign prostatic hyperplasia.